Regulation of cell cycle checkpoints by polo-like kinases

被引:93
作者
Xie, SQ
Xie, B
Lee, MY
Dai, W [1 ]
机构
[1] New York Med Coll, Dept Med, Mol Carcinogenesis Div, Valhalla, NY 10595 USA
[2] New York Med Coll, Brander Canc Res Inst, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Biochem, Mol Carcinogenesis Div, Valhalla, NY 10595 USA
关键词
polo; polo-like kinases; cell cycle; checkpoint; cell division;
D O I
10.1038/sj.onc.1208218
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases play a pivotal role in execution of cell division. Polo and Polo-like kinases have emerged as major regulators for various cell cycle checkpoints. Early genetic studies have demonstrated that CDC5, a budding yeast counterpart of vertebrate Plks, is essential for successful mitotic progression. Mammalian Plks localize primarily to the centrosome during interphase and the mitotic apparatus during mitosis. Many key cell cycle regulators such as p53, Cdc25C, cyclin B, components of the anaphase-promoting complex, and mitotic motor proteins are directly targeted by Plks. Although the exact mechanism of action of these protein kinases in vivo remains to be elucidated, Plks are important mediators for various cell cycle checkpoints that monitor centrosome duplication, DNA replication, formation of bipolar mitotic spindle, segregation of chromosomes, and mitotic exit, thus protecting cells against genetic instability during cell division.
引用
收藏
页码:277 / 286
页数:10
相关论文
共 50 条
[21]   A Plant Ancestral Polo-Like Kinase Sheds Light on the Mystery of the Evolutionary Disappearance of Polo-Like Kinases in the Plant Kingdom [J].
Okamura, Erika ;
Sakamoto, Takuya ;
Sasaki, Tatsuki ;
Matsunaga, Sachihiro .
CYTOLOGIA, 2017, 82 (03) :261-266
[22]   Polo-Like Kinases (Plks) are Prognostic Markers for Gynecologic Malignancies [J].
Takai, Noriyuki ;
Narahara, Hisashi .
CURRENT WOMENS HEALTH REVIEWS, 2008, 4 (04) :266-269
[23]   Schistosoma mansoni Polo-like kinases and their function in control of mitosis and parasite reproduction [J].
Dissous, Colette ;
Grevelding, Christoph G. ;
Long, Thavy .
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2011, 83 (02) :627-635
[24]   The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies [J].
Ward, Alejandra ;
Sivakumar, Gayathri ;
Kanjeekal, Sindu ;
Hamm, Caroline ;
LaBute, Brayden C. ;
Shum, David ;
Hudson, John W. .
LEUKEMIA & LYMPHOMA, 2015, 56 (07) :2123-2133
[25]   Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes [J].
Harris, PLR ;
Zhu, XW ;
Pamies, C ;
Rottkamp, CA ;
Ghanbari, HA ;
McShea, A ;
Feng, Y ;
Ferris, DK ;
Smith, MA .
NEUROBIOLOGY OF AGING, 2000, 21 (06) :837-841
[26]   Polo-like kinases and Chk2 at the interface of DNA damage checkpoint pathways and mitotic regulation [J].
Tsvetkov, L .
IUBMB LIFE, 2004, 56 (08) :449-456
[27]   Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment [J].
Liu, Xiaoqi .
TRANSLATIONAL ONCOLOGY, 2015, 8 (03) :185-195
[28]   Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia [J].
Sparta, Antonino Maria ;
Bressanin, Daniela ;
Chiarini, Francesca ;
Lonetti, Annalisa ;
Cappellini, Alessandra ;
Evangelisti, Cecilia ;
Evangelisti, Camilla ;
Melchionda, Fraia ;
Pession, Andrea ;
Bertaina, Alice ;
Locatelli, Franco ;
McCubrey, James A. ;
Martelli, Alberto M. .
CELL CYCLE, 2014, 13 (14) :2237-2247
[29]   Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma [J].
Pezuk, J. A. ;
Brassesco, M. S. ;
Morales, A. G. ;
de Oliveira, J. C. ;
de Paula Queiroz, R. G. ;
Machado, H. R. ;
Carlotti, C. G., Jr. ;
Neder, L. ;
Scrideli, C. A. ;
Tone, L. G. .
CANCER GENE THERAPY, 2013, 20 (09) :499-506
[30]   From Plk1 to Plk5 Functional evolution of Polo-like kinases [J].
de Carcer, Guillermo ;
Manning, Gerard ;
Malumbres, Marcos .
CELL CYCLE, 2011, 10 (14) :2255-2262